Cell therapy for CNS trauma - PubMed (original) (raw)
Review
Cell therapy for CNS trauma
K K Jain. Mol Biotechnol. 2009 Jul.
Abstract
Cell therapy plays an important role in multidisciplinary management of the two major forms of central nervous system (CNS) injury, traumatic brain injury and spinal cord injury, which are caused by external physical trauma. Cell therapy for CNS disorders involves the use of cells of neural or non-neural origin to replace, repair, or enhance the function of the damaged nervous system and is usually achieved by transplantation of the cells, which are isolated and may be modified, e.g., by genetic engineering, when it may be referred to as gene therapy. Because the adult brain cells have a limited capacity to migrate to and regenerate at sites of injury, the use of embryonic stem cells that can be differentiated into various cell types as well as the use of neural stem cells has been explored. Preclinical studies and clinical trials are reviewed. Advantages as well as limitations are discussed. Cell therapy is promising for the treatment of CNS injury because it targets multiple mechanisms in a sustained manner. It can provide repair and regeneration of damaged tissues as well as prolonged release of neuroprotective and other therapeutic substances.
Similar articles
- Human ciliary neurotrophic factor-overexpressing stable bone marrow stromal cells in the treatment of a rat model of traumatic spinal cord injury.
Abbaszadeh HA, Tiraihi T, Noori-Zadeh A, Delshad AR, Sadeghizade M, Taheri T. Abbaszadeh HA, et al. Cytotherapy. 2015 Jul;17(7):912-21. doi: 10.1016/j.jcyt.2015.03.689. Epub 2015 May 1. Cytotherapy. 2015. PMID: 25939801 - Combination therapies in the CNS: engineering the environment.
McCreedy DA, Sakiyama-Elbert SE. McCreedy DA, et al. Neurosci Lett. 2012 Jun 25;519(2):115-21. doi: 10.1016/j.neulet.2012.02.025. Epub 2012 Feb 17. Neurosci Lett. 2012. PMID: 22343313 Free PMC article. Review. - The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications.
Forostyak S, Jendelova P, Sykova E. Forostyak S, et al. Biochimie. 2013 Dec;95(12):2257-70. doi: 10.1016/j.biochi.2013.08.004. Epub 2013 Aug 27. Biochimie. 2013. PMID: 23994163 Review. - Stem cell repair of central nervous system injury.
Cao Q, Benton RL, Whittemore SR. Cao Q, et al. J Neurosci Res. 2002 Jun 1;68(5):501-10. doi: 10.1002/jnr.10240. J Neurosci Res. 2002. PMID: 12111840 Review. - Dental mesenchymal stem cells and neuro-regeneration: a focus on spinal cord injury.
Bonaventura G, Incontro S, Iemmolo R, La Cognata V, Barbagallo I, Costanzo E, Barcellona ML, Pellitteri R, Cavallaro S. Bonaventura G, et al. Cell Tissue Res. 2020 Mar;379(3):421-428. doi: 10.1007/s00441-019-03109-4. Epub 2019 Nov 27. Cell Tissue Res. 2020. PMID: 31776822 Review.
Cited by
- Current knowledge and challenges associated with targeted delivery of neurotrophic factors into the central nervous system: focus on available approaches.
Bahlakeh G, Rahbarghazi R, Mohammadnejad D, Abedelahi A, Karimipour M. Bahlakeh G, et al. Cell Biosci. 2021 Oct 12;11(1):181. doi: 10.1186/s13578-021-00694-2. Cell Biosci. 2021. PMID: 34641969 Free PMC article. Review. - Cellular therapy for treatment of spinal cord injury in Zebrafish model.
Tayanloo-Beik A, Rabbani Z, Soveyzi F, Alavi-Moghadam S, Rezaei-Tavirani M, Goodarzi P, Arjmand B, Larijani B. Tayanloo-Beik A, et al. Mol Biol Rep. 2021 Feb;48(2):1787-1800. doi: 10.1007/s11033-020-06126-7. Epub 2021 Jan 18. Mol Biol Rep. 2021. PMID: 33459959 Review. - Gene transfer to rat cerebral cortex mediated by polysorbate 80 and poloxamer 188 nonionic surfactant vesicles.
Attia N, Mashal M, Soto-Sánchez C, Martínez-Navarrete G, Fernández E, Grijalvo S, Eritja R, Puras G, Pedraz JL. Attia N, et al. Drug Des Devel Ther. 2018 Nov 16;12:3937-3949. doi: 10.2147/DDDT.S178532. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30510402 Free PMC article. - Neurobehavioural Toxicity of Iron Oxide Nanoparticles in Mice.
Dhakshinamoorthy V, Manickam V, Perumal E. Dhakshinamoorthy V, et al. Neurotox Res. 2017 Aug;32(2):187-203. doi: 10.1007/s12640-017-9721-1. Epub 2017 Mar 20. Neurotox Res. 2017. PMID: 28321581 - MSCs-Derived Exosomes and Neuroinflammation, Neurogenesis and Therapy of Traumatic Brain Injury.
Yang Y, Ye Y, Su X, He J, Bai W, He X. Yang Y, et al. Front Cell Neurosci. 2017 Feb 28;11:55. doi: 10.3389/fncel.2017.00055. eCollection 2017. Front Cell Neurosci. 2017. PMID: 28293177 Free PMC article. Review.
References
- Neurosci Lett. 2004 Aug 19;366(3):287-91 - PubMed
- J Tissue Eng Regen Med. 2009 Mar;3(3):208-17 - PubMed
- Neurosurg Focus. 2008;24(3-4):E18 - PubMed
- Drug Discov Today. 2008 Dec;13(23-24):1082-9 - PubMed
- J Neurosci. 2004 Jul 14;24(28):6402-9 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical